Skip to main content

Table 2 Crude and age- and sex-standardized prevalence and incidence of psoriatic arthritis in Israel by year (2006–2015)

From: The epidemiology of psoriatic arthritis in Israel – a population-based study

Year

Prevalence of PsA

Incidence of PsA

 

Total population (N)

PsA (n)

Crude prevalence (%)

Standardized prevalence (%) (95% CI)a

New PsA (n)

Crude incidence#

Standardized incidencea (95% CI)b

2006

2,620,136

1910

0.073

0.067 (0.065, 0.070)

277

10.6

10.4 (9.5, 11.4)

2007

2,648,067

2132

0.081

0.075 (0.072, 0.077)

251

9.8

9.3 (8.4, 10.3)

2008

2,676,404

2425

0.091

0.084 (0.081, 0.086)

308

11.5

11.4 (10.4, 12.4)

2009

2,705,397

2663

0.098

0.091 (0.088, 0.093)

278

10.3

10.1 (9.2, 11.1)

2010

2,734,705

2938

0.107

0.099 (0.096, 0.102)

303

11.1

11.1 (10.1, 12.1)

2011

2,777,279

3237

0.117

0.107 (0.104, 0.110)

330

11.9

11.7 (10.8, 11.8)

2012

2,816,452

3531

0.125

0.114 (0.111, 0.117)

382

12.5

12.3 (11.3, 13.3)

2013

2,861,934

3866

0.135

0.122 (0.119, 0.125)

354

13.4

13.1 (12.0, 14.1)

2014

2,905,530

4223

0.145

0.131 (0.128, 0.134)

404

13.9

13.5 (12.5, 14.6)

2015

2,931,199

4490

0.153

0.137 (0.134, 0.141)

322

11.0

10.6 (9.7, 11.6)

  1. PsA Psoriatic arthritis
  2. aAge- and sex-standardized to Israel population in 2006
  3. bCrude and standardized rates are per 100,000 population